Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know.

Key Points On the surface, the two companies don't seem as if they'd have much in common. Both benefit from advancing medical technology using AI, however. 10 stocks we like better than Nvidia › In a corporate partnership many investors didn't see coming, chip maker Nvidia (NASDAQ: NVDA) and pharmaceutical company Eli Lilly (NYSE: LLY) say they are collaborating to build and operate a joint research lab. This plan was unveiled at the annual JPMorgan Healthcare Conference in January. The pair, both ...